Related references
Note: Only part of the references are listed.Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation
Jie Huang et al.
BLOOD (2012)
Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia
Yi-Torng Tee et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Is Genetic Screening Necessary for Determining the Possibility of Venous Thromboembolism in Cancer Patients?
Ece Onur et al.
MEDICAL PRINCIPLES AND PRACTICE (2012)
Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity
Juan Gilabert-Estelles et al.
THROMBOSIS RESEARCH (2012)
Impact of uPA System Gene Polymorphisms on the Susceptibility of Environmental Factors to Carcinogenesis and the Development of Clinicopathology of Oral Cancer
Chia-Jui Weng et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk
Carla Y. Vossen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Genetic Polymorphism of the Plasminogen Activator Inhibitor-1 is Associated With an Increased Risk of Endometrial Cancer
Chung-Kuang Su et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Evaluation of the Association of Urokinase Plasminogen Activator System Gene Polymorphisms with Susceptibility and Pathological Development of Hepatocellular Carcinoma
Chia-Jui Weng et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
SERPINE1 Intron Polymorphisms Affecting Gene Expression Are Associated With Diffuse-Type Gastric Cancer Susceptibility
Hyoungseok Ju et al.
CANCER (2010)
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Salvatore Ulisse et al.
CURRENT CANCER DRUG TARGETS (2009)
Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer
E. Vairaktaris et al.
ORAL ONCOLOGY (2009)
Polymorphic Variation of Genes in the Fibrinolytic System and the Risk of Ovarian Cancer
Yaakov Bentov et al.
PLOS ONE (2009)
Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer
Raffaele Palmirotta et al.
THROMBOSIS RESEARCH (2009)
Fibrinolysis: The key to new pathogenetic mechanisms
Esther Zorio et al.
CURRENT MEDICINAL CHEMISTRY (2008)
PAI-1-675 4G/5G polymorphism as a prognostic biomarker in breast cancer
Haixin Lei et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Polymorphisms in the genes of the urokinase plasminogen activation system in relation to colorectal cancer
A. Foersti et al.
ANNALS OF ONCOLOGY (2007)
Clinical implications of matrix metalloproteinase-1,-3,-7,-9,-12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer
Mijung Woo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Markers of the uPA system and common prognostic factors in breast cancer
Alessandro Marco Minisini et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Plasminogen activator inhibitor type-I (PAI-I) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history
Eric Jorgenson et al.
PROSTATE (2007)
The Plasminogen Activator System and Cancer
Brandon McMahon et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2007)
Prognostic value of PAI1 in invasive breast cancer: Evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression
Mark D. Sternlicht et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity
R Castello et al.
THROMBOSIS RESEARCH (2006)
Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity
Hayley Morgan et al.
CANCER CELL INTERNATIONAL (2005)
The urokinase plasminogen activator system: Role in malignancy
MJ Duffy
CURRENT PHARMACEUTICAL DESIGN (2004)
The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia
MT Sartori et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2003)
The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy
N Sidenius et al.
CANCER AND METASTASIS REVIEWS (2003)
Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis
A Loktionov et al.
CANCER LETTERS (2003)
uPAR: A versatile signalling orchestrator
F Blasi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis
MS Pepper
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
Share Paper
